Armata Pharmaceuticals logo

Armata Pharmaceuticals share price today

(ARMP)

Armata Pharmaceuticals share price is $1.85 & ₹158.45 as on 1 Jan 2025, 2.30 'hrs' IST

$1.85

-0.05

(-2.63%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Armata Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Armata Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Armata Pharmaceuticals. Get details on the Indian mutual funds that are investing in Armata Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Armata Pharmaceuticals's financials.

Armata Pharmaceuticals share price movements

  • Today's Low: $1.85
    Today's High: $1.93

    Day's Volatility :4.3%

  • 52 Weeks Low: $1.80
    52 Weeks High: $4.48

    52 Weeks Volatility :59.82%

Armata Pharmaceuticals Returns

PeriodArmata Pharmaceuticals IncIndex (Russel 2000)
3 Months
-19.57%
0.0%
6 Months
-30.71%
0.0%
1 Year
-34.16%
0.0%
3 Years
-68.48%
-21.2%

Armata Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$1.9
Open
$1.87
Today's High
$1.9331
Today's Low
$1.85
Market Capitalization
$66.9M
Today's Volume
$9.6K
52 Week High
$4.48
52 Week Low
$1.8
Revenue TTM
$3.7M
EBITDA
$-40.9M
Earnings Per Share (EPS)
$-1.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3439.35%

How to invest in Armata Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Armata Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Armata Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Armata Pharmaceuticals or ARMP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Armata Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Armata Pharmaceuticals shares which would translate to 0.463 fractional shares of Armata Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Armata Pharmaceuticals, in just a few clicks!

Returns in Armata Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Armata Pharmaceuticals investment value today

Current value as on today

₹68,703

Returns

₹31,297

(-31.3%)

Returns from Armata Pharmaceuticals Stock

₹34,164 (-34.16%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Armata Pharmaceuticals

71%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Armata Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 71% more investors are searching Armata Pharmaceuticals in the last 30 days versus the previous period.

Analyst Recommendation on Armata Pharmaceuticals

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Armata Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Armata Pharmaceuticals

What analysts predicted

Upside of 278.38%

Current:

$1.85

Target:

$7.00

Insights on Armata Pharmaceuticals

  • Price Movement

    In the last 7 days, ARMP stock has moved down by -8.4%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.52M → 966.0K (in $), with an average decrease of 36.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 8.98M → -5.48M (in $), with an average decrease of 161.0% per quarter
  • ARMP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 61.0%
  • ARMP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 105.0%
  • Price to Sales

    ForARMP every $1 of sales, investors are willing to pay $18.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Armata Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Armata Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Armata Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Armata Pharmaceuticals Inc
-13.55%
-30.71%
-34.16%
-68.48%
-40.32%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-22.37%
13.59%
91.62%
Biontech Se
-1.42%
42.28%
3.53%
-50.85%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
23.43%
35.31%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-1.95%
80.96%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Armata Pharmaceuticals Inc
NA
NA
NA
-0.95
-34.39
-0.25
NA
-0.89
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Armata Pharmaceuticals Inc
Buy
$66.9M
-40.32%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Armata Pharmaceuticals

c3 jian is a well-capitalized, private, los angeles based biotechnology company advancing novel compounds that target unmet medical/dental needs related primarily to oral healthcare. the company's lead compound is a unique peptide drug against dental caries (i.e. tooth decay). the company’s lead compound started fda-regulated phase ii human clinical trials in early 2014. c3 jian's platform technology has also yielded peptides that can affect calcification processes, including not only tooth sensitivity but possibly hair and nail growth as well. the company has recently moved its operations to a new facility in marina del rey. the company was founded based on technology created in the laboratory of dr. wenyuan shi, chair of the department of oral biology at the university of california, los angeles school of dentistry. for more information about the company and to explore career opportunities at c3 jian please visit our webpage at www.c3-jian.com
Organization
Armata Pharmaceuticals
Employees
66
CEO
Dr. Deborah L. Birx M.D.
Industry
Biotechnology

Management People of Armata Pharmaceuticals

NameTitle
Dr. Deborah L. Birx M.D.
CEO & Director
Dr. Mina Pastagia M.D., MS
Chief Medical Officer
Mr. David House
Senior VP of Finance & Principal Financial Officer
Mr. Peter Hubbard
Vice President of Operations
Dr. Pierre Kyme Ph.D.
Chief Business Officer

Important FAQs about investing in Armata Pharmaceuticals from India :

What is Armata Pharmaceuticals share price today?

Armata Pharmaceuticals share price today stands at $1.85, Open: $1.87 ; Previous Close: $1.90 ; High: $1.93 ; Low: $1.85 ; 52 Week High: $4.48 ; 52 Week Low: $1.80. The stock opens at $1.87, after a previous close of $1.90. The stock reached a daily high of $1.93 and a low of $1.85, with a 52-week high of $4.48 and a 52-week low of $1.80.

Can Indians buy Armata Pharmaceuticals shares?

Yes, Indians can invest in the Armata Pharmaceuticals (ARMP) from India.

With INDmoney, you can buy Armata Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Armata Pharmaceuticals at zero transaction cost.

How can I buy Armata Pharmaceuticals shares from India?

It is very easy to buy Armata Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Armata Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Armata Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Armata Pharmaceuticals stocks?

To start investing in Armata Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Armata Pharmaceuticals

Today’s highest price of Armata Pharmaceuticals (ARMP) is $1.93.

Today’s lowest price of Armata Pharmaceuticals (ARMP) is $1.85.

What is today's market capitalisation of Armata Pharmaceuticals

Today's market capitalisation of Armata Pharmaceuticals ARMP is 66.9M

What is the 52 Week High and Low Range of Armata Pharmaceuticals

  • 52 Week High

    $4.48

  • 52 Week Low

    $1.80

What are the historical returns of Armata Pharmaceuticals?

  • 1 Month Returns

    -13.55%

  • 3 Months Returns

    -30.71%

  • 1 Year Returns

    -34.16%

  • 5 Years Returns

    -40.32%

Who is the Chief Executive Officer (CEO) of Armata Pharmaceuticals

Dr. Deborah L. Birx M.D. is the current Chief Executive Officer (CEO) of Armata Pharmaceuticals.